Jonathan Berman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jonathan Berman

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Malaria Journal|December 8, 2016

Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.

The American Journal of Tropical Medicine and Hygiene|July 8, 2011

Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in BangladeshMahmudur Rahman, Be-Nazir Ahmed, M Abul Faiz, et al.

The New England Journal of Medicine|February 8, 2013

Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Malaria Journal|December 8, 2016

Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium bergheiErin E Milner, Jonathan Berman, Diana Caridha, et al.

The American Journal of Tropical Medicine and Hygiene|July 8, 2011

Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in BangladeshMahmudur Rahman, Be-Nazir Ahmed, M Abul Faiz, et al.

The New England Journal of Medicine|February 8, 2013

Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.

Pageof 6